Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases

Tsuneo Takenaka1, Taku Mimura, Yoshihiko Kanno

  • 1Department of Nephrology, Saitama Medical College, 38 Moro-hongo Moroyama, Iruma Saitama 350-0495, Japan.

Insights

Augmentation index (AI), a measure of arterial stiffness, is linked to worsening non-diabetic chronic kidney disease (CKD) and left ventricular hypertrophy. Higher AI indicates increased risk for CKD progression.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Biomedical Engineering

Background:

  • Arterial stiffness, assessed by augmentation index (AI), may impact chronic kidney disease (CKD) progression.
  • The specific relationship between AI and non-diabetic CKD progression requires further characterization.

Purpose of the Study:

  • To investigate the association between augmentation index (AI) and the progression of non-diabetic chronic kidney diseases (CKDs).
  • To explore the role of AI in the development of left ventricular hypertrophy in patients with non-diabetic CKD.

Main Methods:

  • Pulse wave analysis was used to determine AI in 99 patients with non-diabetic CKDs.
  • Echocardiography was performed in 51 patients to assess left ventricular mass index.
  • Creatinine clearance was measured repeatedly in 41 patients to monitor CKD progression.

Main Results:

  • AI positively correlated with age and weight, and negatively with height and heart rate (R(2) = 0.50).
  • Elevated AI was associated with increased left ventricular mass index in male patients under angiotensin inhibition (r = 0.33, p < 0.05).
  • Higher baseline AI predicted a greater annual decrease in creatinine clearance in patients on angiotensin inhibition (r = -0.52, p < 0.01).

Conclusions:

  • Augmentation index (AI) and angiotensin contribute to left ventricular hypertrophy.
  • AI is identified as a risk factor for the progression of non-diabetic CKDs, independent of angiotensin.
  • These findings highlight AI as a potential therapeutic target in managing non-diabetic CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...